Efficacy and Safety of Varenicline for Adolescent Smoking Cessation | Zendy

Kevin M. Gray | Zendy; Nathaniel L. Baker | Zendy; Erin A. McClure | Zendy; Rachel L. Tomko | Zendy; Lindsay M. Squeglia | Zendy; Michael E. Saladin | Zendy; Matthew J. Carpenter | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Varenicline for Adolescent Smoking Cessation

Author(s) -

Kevin M. Gray,

Nathaniel L. Baker,

Erin A. McClure,

Rachel L. Tomko,

Lindsay M. Squeglia,

Michael E. Saladin,

Matthew J. Carpenter

Publication year - 2019

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2019.3553

Subject(s) - medicine , varenicline , smoking cessation , abstinence , randomized controlled trial , cotinine , pediatrics , nicotine , psychiatry , pathology

Cigarette smoking is the leading cause of preventable morbidity and mortality in the United States and worldwide, and most tobacco users begin smoking in adolescence. Although advances have yielded efficacious pharmacotherapies to complement smoking cessation counseling in adults, far less progress has been made in addressing tobacco use in adolescence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research